Department of Pediatrics / Endocrinology Division / Research Publications

Research Publications

1. McHan L
2. Gupta J
Thyrotoxicosis Due to Acute Suppurative Thyroiditis in a Pediatric Patient: A Case Report; Journal of Investigative Medicine High Impact Case Reports.. 2022 Jan 01.
1. Gupta J
2. Antal Z
3. Mauer E
4. Gerber LM
5. An A
6. Censani M
Dysglycemia screening with oral glucose tolerance test in adolescents with polycystic ovary syndrome and relationship with obesity.; BMC Endocr Disord. 2022 Jan 01.
1. Gupta J
Outpatient pediatric care and vaccination during COVID-19 pandemic-parental outlook and access to healthcare; Opinion article. 2021 Jan 01.
1. Gupta J
"Van Wyk-Grumbach syndrome in a female pediatric patient with trisomy 21: a case report"; International journal of pediatric endocrinology. 2020 Jan 01.
1. Gupta J
2. Antal Z
3. Censani M
Prevalence of Impaired Glucose Tolerance in Adolescent Patients with Polycystic Ovary Syndrome in an Urban Health Care Center.; American Diabetes Association; Vol 67(Issue Supplement 1). 2018 Jan 01.
1. Gupta J
Knowledge, attitude and practices to hypothermia amongst nursing professionals and mothers of neonates.; Literature Review. 2010 Jan 01.
1. Svoren BM
2. Volkening LK
3. Wood JR
4. Laffel LM
Significant vitamin D deficiency in youth with type 1 diabetes mellitus; The Journal of Pediatrics; Vol 154(1), pp. 132-4. 2009 Jan 01.
1. Robinson DM
2. Meagher CC
3. Orlowski CC
4. Lagoe EC
5. Fong CT
Young-Simpson syndrome (YSS), a variant of del(1)(p36) syndrome?; American journal of medical genetics. Part A; Vol 146A(12), pp. 1571-4. 2008 Jun 15.
1. Svoren BM
2. Volkening LK
3. Butler DA
4. Moreland EC
5. Anderson BJ
6. Laffel LM
Temporal trends in the treatment of pediatric type 1 diabetes and impact on acute outcomes; The Journal of Pediatrics; Vol 150(3), pp. 279-85. 2007 Jan 01.
1. Rodacki M
2. Svoren B
3. Butty V
4. Besse W
5. Laffel L
6. Benoist C
7. Mathis D
Altered natural killer cells in type 1 diabetic patients.; Diabetes; Vol 56(1), pp. 177-85. 2007 Jan.
1. Wood JR
2. Moreland EC
3. Volkening LK
4. Svoren BM
5. Butler DA
6. Laffel LM
Durability of insulin pump use in pediatric patients with type 1 diabetes; Diabetes Care; Vol 29(11), pp. 2355-60. 2006 Jan 01.
1. Goddard DS
2. Liang MG
3. Chamlin SL
4. Svoren BM
5. Spack NP
6. Mulliken JB
Hypopituitarism in PHACES Association; Pediatric Dermatology; Vol 23(5), pp. 476-80. 2006 Jan 01.
1. Smith VC
2. Svoren BM
3. Wolfsdorf JI
Hypothyroidism in a breast-fed preterm infant resulting from maternal topical iodine exposure; The Journal of Pediatrics; Vol 149(4), pp. 566-7. 2006 Jan 01.
1. Mack-Fogg JE
2. Orlowski CC
3. Jospe N
Continuous subcutaneous insulin infusion in toddlers and children with type 1 diabetes mellitus is safe and effective.; Pediatric diabetes; Vol 6(1), pp. 17-21. 2005 Mar.
1. Svoren BM
2. Wolfsdorf JI
Sexual development in a 21 month-old boy caused by testosterone contamination of a topical hydrocortisone cream; Journal of Pediatric Endocrinology & Metabolism: JPEM; Vol 18(5), pp. 507-10. 2005 Jan 01.
1. Norris AW
2. Svoren BM
Complications and comorbidites of type 2 diabetes; Pediatric Annals; Vol 34(9), pp. 710-8. 2005 Jan 01.
1. Arnold GL
2. Vladutiu CJ
3. Orlowski CC
4. Blakely EM
5. DeLuca J
Prevalence of stimulant use for attentional dysfunction in children with phenylketonuria.; Journal of inherited metabolic disease; Vol 27(2), pp. 137-43. 2004.
1. Svoren BM
2. Butler D
3. Levine BS
4. Anderson BJ
5. Laffel LM
Reducing acute adverse outcomes in youths with type 1 diabetes: a randomized, controlled trial.; Pediatrics; Vol 112(4), pp. 914-22. 2003 Oct.
1. Charafeddine L
2. D'Angio CT
3. Richards JL
4. Stripp BR
5. Finkelstein JN
6. Orlowski CC
7. LoMonaco MB
8. Paxhia A
9. Ryan RM
Hyperoxia increases keratinocyte growth factor mRNA expression in neonatal rabbit lung.; The American journal of physiology; Vol 276(1 Pt 1). 1999 Jan.
1. Harris JP
2. Garfunkel LC
3. Orlowski CC
Expanding the pediatrics residency curriculum.; Academic medicine : journal of the Association of American Medical Colleges; Vol 72(5), pp. 451-2. 1997 May.
1. Orlowski CC
2. Furlanetto RW
The mammalian cell cycle in normal and abnormal growth.; Endocrinology and metabolism clinics of North America; Vol 25(3), pp. 491-502. 1996 Sep.
1. Jospe N
2. Orlowski CC
3. Furlanetto RW
Comparison of transdermal and oral estrogen therapy in girls with Turner's syndrome.; Journal of pediatric endocrinology & metabolism : JPEM; Vol 8(2), pp. 111-6. 1995 Apr.
1. Orlowski CC
2. Ooi GT
3. Brown DR
4. Yang YW
5. Tseng LY
6. Rechler MM
Insulin rapidly inhibits insulin-like growth factor-binding protein-1 gene expression in H4-II-E rat hepatoma cells.; Molecular endocrinology (Baltimore, Md.); Vol 5(8), pp. 1180-7. 1991 Aug.
1. Rechler MM
2. Brown AL
3. Ooi GT
4. Orlowski CC
5. Tseng LY
6. Yang YW
Regulation of gene expression of rat insulin-like growth factor binding proteins 1 and 2.; Advances in experimental medicine and biology; Vol 293, pp. 137-48. 1991.
1. Straus DS
2. Ooi GT
3. Orlowski CC
4. Rechler MM
Expression of the genes for insulin-like growth factor-I (IGF-I), IGF-II, and IGF-binding proteins-1 and -2 in fetal rat under conditions of intrauterine growth retardation caused by maternal fasting.; Endocrinology; Vol 128(1), pp. 518-25. 1991 Jan.
1. Orlowski CC
2. Ooi GT
3. Rechler MM
Dexamethasone stimulates transcription of the insulin-like growth factor-binding protein-1 gene in H4-II-E rat hepatoma cells.; Molecular endocrinology (Baltimore, Md.); Vol 4(10), pp. 1592-9. 1990 Oct.
1. Ooi GT
2. Orlowski CC
3. Brown AL
4. Becker RE
5. Unterman TG
6. Rechler MM
Different tissue distribution and hormonal regulation of messenger RNAs encoding rat insulin-like growth factor-binding proteins-1 and -2.; Molecular endocrinology (Baltimore, Md.); Vol 4(2), pp. 321-8. 1990 Feb.
1. Yang YW
2. Brown AL
3. Orlowski CC
4. Graham DE
5. Tseng LY
6. Romanus JA
7. Rechler MM
Identification of rat cell lines that preferentially express insulin-like growth factor binding proteins rlGFBP-1, 2, or 3.; Molecular endocrinology (Baltimore, Md.); Vol 4(1), pp. 29-38. 1990 Jan.
1. Orlowski CC
2. Brown AL
3. Ooi GT
4. Yang YW
5. Tseng LY
6. Rechler MM
Tissue, developmental, and metabolic regulation of messenger ribonucleic acid encoding a rat insulin-like growth factor-binding protein.; Endocrinology; Vol 126(1), pp. 644-52. 1990 Jan.
1. Tseng LY
2. Brown AL
3. Yang YW
4. Romanus JA
5. Orlowski CC
6. Taylor T
7. Rechler MM
The fetal rat binding protein for insulin-like growth factors is expressed in the choroid plexus and cerebrospinal fluid of adult rats.; Molecular endocrinology (Baltimore, Md.); Vol 3(10), pp. 1559-68. 1989 Oct.
1. Yang YW
2. Wang JF
3. Orlowski CC
4. Nissley SP
5. Rechler MM
Structure, specificity, and regulation of the insulin-like growth factor-binding proteins in adult rat serum.; Endocrinology; Vol 125(3), pp. 1540-55. 1989 Sep.
1. Orlowski CC
2. Chernausek SD
3. Akeson R
Actions of insulin-like growth factor-I on the B104 neuronal cell line: effects on cell replication, receptor characteristics, and influence of secreted binding protein on ligand binding.; Journal of cellular physiology; Vol 139(3), pp. 469-76. 1989 Jun.
1. Brown AL
2. Chiariotti L
3. Orlowski CC
4. Mehlman T
5. Burgess WH
6. Ackerman EJ
7. Bruni CB
8. Rechler MM
Nucleotide sequence and expression of a cDNA clone encoding a fetal rat binding protein for insulin-like growth factors.; The Journal of biological chemistry; Vol 264(9), pp. 5148-54. 1989 Mar 25.
1. Orlowski CC
2. Chernausek SD
Discordance of serum and tissue somatomedin levels in growth hormone-stimulated growth in the rat.; Endocrinology; Vol 123(1), pp. 44-9. 1988 Jul.
1. Meisler M
2. Orlowski C
3. Gross E
4. Bloor JH
Cadmium metabolism in cdm/cdm mice.; Biochemical genetics; Vol 17(7-8), pp. 731-6. 1979 Aug.